Trial intelligence / Profile preview

Comparison of Propofol-based Total Intravenous Anesthesia vs Desflurane Anesthesia on NK Cell Activity After Major Hepatic Resection

TCTR20190423003Not yet recruiting

Sponsor
Ratchadaphiseksomphot Endowment Fund
Start
Jun 2019
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Trial of propofol and desflurane in hepatocellular carcinoma (HCC) (2 arms), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: NK cell activity. Planned start Jun 2019; status: not yet recruiting.

02

Drugs

propofoldesflurane
03

Conditions

hepatocellular carcinoma (HCC)

Beyond the preview

Go deeper on TCTR20190423003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20190423003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call